Cargando…
Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
Autores principales: | Yu, Kaikai, Liu, Bin, Yu, Haotian, Sun, Chengbiao, Wang, Xuefeng, Li, Guorui, Dong, Mingxin, Wang, Yan, Zhang, Jianxu, Xu, Na, Liu, Wensen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484629/ https://www.ncbi.nlm.nih.gov/pubmed/37692173 http://dx.doi.org/10.3389/fcimb.2023.1264974 |
Ejemplares similares
-
A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
por: Yu, Kaikai, et al.
Publicado: (2023) -
Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals
por: Mader, Anna-Lena, et al.
Publicado: (2022) -
Recombinant Ricin Toxin Binding Subunit B (RTB) Stimulates Production of TNF-α by Mouse Macrophages Through Activation of TLR4 Signaling Pathway
por: Xu, Na, et al.
Publicado: (2020) -
CircEpc1 Promotes Ricin Toxin-Induced Inflammation via Activation of NF-κB and MAPK Signaling Pathways by Sponging miR-5114
por: Dong, Mingxin, et al.
Publicado: (2021) -
Enhancing the antivirus activity of chimeric canine interferon with ricin subunit B by using nanoparticle formulations
por: Sun, Chengbiao, et al.
Publicado: (2020)